The WHIP COVID-19 Study: The Use of Hydroxychloroquine as Prophylaxis for COVID-19

William W O'Neill, MD, Detroit, MI
Interviewer: Spencer B. King III, MD, MACC, Atlanta, GA

Listen to ACCEL Editor-in-Chief Dr. Spencer B. King III, MD, MACC interview Dr. William W. O’Neill, professor at Henry Ford Hospital Detroit and world-renowned interventional cardiologist, regarding his latest trial, the WHIP COVID-19 (Will Hydroxychloroquine Impede or Prevent COVID-19) study. In this approximately 9-minute interview, Dr. O’Neill discusses and details the ambitious and pioneering study, which will enroll over 3,000 healthcare workers and first responders to test whether the anti-malarial drug hydroxychloroquine can prevent these frontline workers from contracting COVID-19.

The WHIP COVID-19 Study:
The Use of Hydroxychloroquine as Prophylaxis for COVID-19

LISTEN TO MORE LECTURES:

Neurologic Manifestations of SARS-CoV-2 Infection from Continuum^® Audio ⟶

COVID-19: Exploring the Behavior of SARS-CoV-2 ⟶

Geriatric Patients And COVID-19 ⟶

Targetable Biological Mechanisms Implicated in Emergent Psychiatric Conditions Associated with SARS-CoV-2 Infection ⟶

Geriatric Patients And COVID-19 ⟶

COVID-19 in Children ⟶

Clinical Update on COVID-19 ⟶

COVID-19 and Mental Health ⟶

COVID-19 and Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs)⟶

Circulation on the Run: Special COVID-19 Edition⟶

Post-Viral Olfactory Loss (PVOL): Insights in the Age of the COVID-19 Pandemic⟶

Facing COVID-19: Lessons Learned from Italy ⟶

Coding in the World of COVID-19: Non-Face-to-Face Evaluation and Management Care ⟶

COVID-19 and Anxiety: Actionable Tools for the Care Team ⟶

What is Coronavirus Disease (COVID-19) and What Doctors Need to Know ⟶